Abridge: $250 Million (Series D) Raised To Advance GenAI Platform Clinical Conversations
By Amit Chowdhry ● Feb 17, 2025
Abridge, a leading generative AI (GenAI) platform for clinical conversations, announced it has raised a $250 million Series D investment, coinciding with the milestone of surpassing 100 deployments at some of the largest and most complex health systems in the US. This funding round was co-led by Elad Gil and IVP, and it also includes contributions from Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures (NVIDIA’s venture capital arm), Redpoint Ventures, Spark Capital, and SV Angel.